Developer docs
API playgroundTry for free, no card

Search company profiles

Cambridge Capital Group

Full company profile

uuid0005yzp

Namestring
Cambridge Capital Group
Legal namestring
Cambridge Capital Group
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Cambridge Capital Group is a private business angel network founded in 2000 and headquartered at The Bradfield Centre on Cambridge Science Park in the United Kingdom. The organization is a syndicate of over 80 private investors, family offices, and venture funds that deploys early-stage capital into high-technology startups across the UK's Golden Triangle (Cambridge, London, and Oxford). Cambridge Capital Group does not develop proprietary technology products; instead, it operates an investment-facilitation platform comprising monthly online pitching events, quarterly face-to-face investment events, and an exclusive online deal-flow platform where members review screened opportunities and collaborate on due diligence. The group targets seed and Series A rounds raising between £100,000 and £2m in S/EIS-eligible equity, primarily into technology segments where Cambridge is strong: engineering, materials, medtech and biotech, AI/ML/robotics, and B2B digital services.

Over its 25-year history, Cambridge Capital Group has invested more than £50 million across over 100 portfolio companies and recorded 22 exits via AIM listings and trade sales. Notable outcomes include the 2016 sale of SwiftKey to Microsoft for $250 million (~10X return to angel investors), the 2024 sale of Featurespace to Visa in a $1 billion transaction, and the 2024 sale of IQ Geo to KKR. Individual investment outcomes for members have ranged from 2X to 15X. The network operates without FCA regulation; members self-certify as High Net Worth Individuals or Sophisticated Investors. Its sub-brands include CCG International, which extends reach to international family offices for growth-stage follow-on capital, and The CCG Trust (Investors In Wildlife), a separately constituted charitable entity.

The business model is an investment syndication model rather than a fee-for-service business. Cambridge Capital Group does not charge entrepreneurs direct fees; it generates returns for members through capital appreciation of portfolio companies, typically targeting 5X+ outcomes over a 5–8 year horizon. The organization is led by two directors — founder and chairman Struan McDougall and managing director Jayne Parker — and is supported by a network of corporate sponsors (Potter Clarkson LLP, RSM, HCR Hewitsons, British Business Bank, Bailey Fisher, Dartington Wealth Management, Letts Group) that provide IP legal, financial advisory, and wealth management services to portfolio companies and members.

Short descriptiontext

Cambridge Capital Group is a private business angel network of 80+ investors that has deployed over £50M into 100+ UK Golden Triangle technology startups since 2000, generating 22 exits through syndicated seed-to-Series A rounds.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCambridge, United Kingdom
HQ citystring
Cambridge
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
business angel network, early-stage investment, venture capital syndication, seed stage funding, technology startup investing
Industry4 codes
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
SECONDARYFSAEAMAE
Private Capital Introducers (PE/VC/Private Credit)
SECONDARYFSAAADAH
Family Office Investment Platforms & Direct Investing (PE/VC/Co-Invest)
Financial & Insurance/Asset & Wealth Management/Family Offices (Single- & Multi-Family)
SECONDARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
NAICS code3 codes
  • Portfolio Management and Investment Advice52394
  • Other Financial Investment Activities5239
  • All Other Financial Investment Activities52399
SIC code2 codes
  • Investors, Nec6799
  • Investment Advice6282
Product category
Angel Investment / Venture Capital
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Returns
TypeTransaction Fee
Description

Cambridge Capital Group generates returns through capital appreciation of portfolio companies. Members invest in early-stage technology startups with the expectation of 5X+ returns within 5-8 years through exits via AIM listings or trade sales. The network itself does not charge direct fees to entrepreneurs but facilitates connections between investors and startups.

cambridgecapitalgroup.co.uk
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Operations, Marketing or Sales, Personnel, Others
Pricing details1 tier
1Individual member investments
ModelOtherBilling cadenceMulti-year contract
Notes

Members invest alongside specialist funds and participate in funding rounds syndicated with partner networks. Some companies have received £10k from a single member, others have received £1m-2m from a group syndicate.

cambridgecapitalgroup.co.uk
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1CCG International
Description

International network of private investors providing well-screened investment opportunities in hi-tech sectors including engineering, internet, software, artificial intelligence, medtech, biotech, electronics, fintech and wireless communications.

cambridgecapitalgroup.co.uk
+1 more record
Core offering1 text field

Cambridge Capital Group is a business angel network of 80+ private investors, family offices, and venture funds that screens, sources, and syndicates seed-to-Series A equity investments into early-stage technology startups in the UK's Golden Triangle. The group facilitates investments between £100,000 and £2m in S/EIS eligible equity financing via monthly online pitching events, quarterly in-person events, and an exclusive online deal flow platform, targeting 5X+ returns over a 5-8 year horizon through AIM listings and trade sales.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 22 successful exits via AIM listings and trade sales
+3 more records
Product overview1 text field

Cambridge Capital Group is a private business angel network, not a product company. It does not offer a unified product platform or software products. Instead, it provides investment services connecting angel investors with early-stage technology startups in the UK's Golden Triangle (Cambridge, London, Oxford). The organization facilitates deal flow screening, investment pitching events (monthly online and quarterly face-to-face), syndicated investments, and due diligence collaboration among its members. The investment vehicle itself is not a product offering in the traditional SaaS or technology product sense.

Product and service1 record
1Angel Investment Syndication Service
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeGTM or Marketing Partner
Description

Corporate sponsor and dinner sponsor for CCG events. Provides investment expertise and networking for members.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Corporate sponsor providing IP legal advice and guidance to CCG portfolio companies.

3RSM
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Corporate sponsor providing financial advisory services to CCG and portfolio companies.

cambridgecapitalgroup.co.uk
4HCR Hewitsons
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Corporate sponsor providing legal services to CCG and portfolio companies.

cambridgecapitalgroup.co.uk
Strategic tierMinorTypeGTM or Marketing Partner
Description

Corporate sponsor providing incubator and advisory services. Dinner sponsor for CCG events.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

International network of private investors for growth stage investment in portfolio companies. Extends CCG's reach to family offices, private trusts, and international investors in hi-tech sectors.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cambridge-based business angel network investing in early-stage technology companies spun out of the University of Cambridge and the wider UK tech ecosystem. Directly comparable in geography, deal stage (seed to Series A), and member profile to Cambridge Capital Group.

TypeDirect peer
Description

One of the UK's most established angel networks, operating in the London market and investing in seed to Series A technology startups. Directly comparable in deal stage, member composition, and structured event-based pitch process.

3QantX
TypeEmerging player
Description

Early-stage investor in healthtech and deeptech, based in the Cambridge/South West UK ecosystem and co-investing with CCG (e.g., iFAST Diagnostics). Comparable as a regional specialist investor in deep tech, with a more focused sector mandate.

TypeBroad incumbent
Description

UK government-backed development bank that sponsors CCG events and supports SME investment through programmes such as the Angel CoFund. Comparable in supporting the UK angel ecosystem and providing catalytic capital to early-stage ventures.

TypeBroad incumbent
Description

One of the UK's largest venture capital firms, actively investing across seed to growth stages in UK technology. Comparable as a co-investor in Cambridge ecosystem deals (e.g., SwiftKey) but at materially larger AUM and broader sector mandate.

TypeDirect peer
Description

Oxford-based angel network focused on early-stage investment opportunities emerging from the Oxford innovation ecosystem. Directly comparable as a Golden Triangle angel network with similar member-driven, event-based deal-sourcing model.

TypeEmerging player
Description

Online angel investment platform that uses a 'funding circle' model to allow members to co-invest in early-stage UK companies. Comparable in providing HNW investors with diversified early-stage deal flow, but with a digital-first delivery model.

TypeDirect peer
Description

Cambridge-based life science and healthcare seed fund that co-invests with CCG in life sciences opportunities. Comparable in early-stage focus and Cambridge cluster positioning, though specialized in the life sciences vertical.

9Cambridge Enterprise Ventures
TypeDirect peer
Description

University of Cambridge's technology transfer and seed investment arm, leading funding rounds in Cambridge spinouts. Directly comparable as the most active co-investor in CCG's deal flow and the principal source of Cambridge spinout deal flow.

TypeDirect peer
Description

UK-based investor in university spinouts from the Golden Triangle, frequently co-investing with CCG (e.g., Semarion). Comparable as an early-stage technology investor focused on Cambridge and Oxford spinouts with similar return profile.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment45 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cambridge Capital Group

Angel Investment / Venture Capitalcambridgecapitalgroup.co.uk

Cambridge Capital Group is a private business angel network of 80+ investors that has deployed over £50M into 100+ UK Golden Triangle technology startups since 2000, generating 22 exits through syndicated seed-to-Series A rounds.

What Cambridge Capital Group does

Cambridge Capital Group is a private business angel network founded in 2000 and headquartered at The Bradfield Centre on Cambridge Science Park in the United Kingdom. The organization is a syndicate of over 80 private investors, family offices, and venture funds that deploys early-stage capital into high-technology startups across the UK's Golden Triangle (Cambridge, London, and Oxford). Cambridge Capital Group does not develop proprietary technology products; instead, it operates an investment-facilitation platform comprising monthly online pitching events, quarterly face-to-face investment events, and an exclusive online deal-flow platform where members review screened opportunities and collaborate on due diligence. The group targets seed and Series A rounds raising between £100,000 and £2m in S/EIS-eligible equity, primarily into technology segments where Cambridge is strong: engineering, materials, medtech and biotech, AI/ML/robotics, and B2B digital services.

Over its 25-year history, Cambridge Capital Group has invested more than £50 million across over 100 portfolio companies and recorded 22 exits via AIM listings and trade sales. Notable outcomes include the 2016 sale of SwiftKey to Microsoft for $250 million (~10X return to angel investors), the 2024 sale of Featurespace to Visa in a $1 billion transaction, and the 2024 sale of IQ Geo to KKR. Individual investment outcomes for members have ranged from 2X to 15X. The network operates without FCA regulation; members self-certify as High Net Worth Individuals or Sophisticated Investors. Its sub-brands include CCG International, which extends reach to international family offices for growth-stage follow-on capital, and The CCG Trust (Investors In Wildlife), a separately constituted charitable entity.

The business model is an investment syndication model rather than a fee-for-service business. Cambridge Capital Group does not charge entrepreneurs direct fees; it generates returns for members through capital appreciation of portfolio companies, typically targeting 5X+ outcomes over a 5–8 year horizon. The organization is led by two directors — founder and chairman Struan McDougall and managing director Jayne Parker — and is supported by a network of corporate sponsors (Potter Clarkson LLP, RSM, HCR Hewitsons, British Business Bank, Bailey Fisher, Dartington Wealth Management, Letts Group) that provide IP legal, financial advisory, and wealth management services to portfolio companies and members.

Cambridge Capital Group firmographics

Firmographics
Name
Cambridge Capital Group
Legal name
Cambridge Capital Group
Website
https://cambridgecapitalgroup.co.uk
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
Cambridge Capital Group is a private business angel network of 80+ investors that has deployed over £50M into 100+ UK Golden Triangle technology startups since 2000, generating 22 exits through syndicated seed-to-Series A rounds.
Ownership category
akta.pro rank

Cambridge Capital Group industry classification

Industry
Product category
Angel Investment / Venture Capital
NAICS
Portfolio Management and Investment Advice (52394), Other Financial Investment Activities (5239), All Other Financial Investment Activities (52399)
SIC
Investors, Nec (6799), Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
SECONDARYFSAEAMAE
Private Capital Introducers (PE/VC/Private Credit)
SECONDARYFSAAADAH
Family Office Investment Platforms & Direct Investing (PE/VC/Co-Invest)
Financial & Insurance/Asset & Wealth Management/Family Offices (Single- & Multi-Family)
SECONDARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)

Keywords

  • Business angel network
  • Early-stage investment
  • Venture capital syndication
  • Seed stage funding
  • Technology startup investing

Where Cambridge Capital Group is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Cambridge Capital Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Marketing or Sales, Personnel, Others

Revenue model

  1. Investment Returns: Cambridge Capital Group generates returns through capital appreciation of portfolio companies. Members invest in early-stage technology startups with the expectation of 5X+ returns within 5-8 years through exits via AIM listings or trade sales. The network itself does not charge direct fees to entrepreneurs but facilitates connections between investors and startups.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractIndividual member investments

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Cambridge Capital Group product offering

Product offering

Core offering

Cambridge Capital Group is a business angel network of 80+ private investors, family offices, and venture funds that screens, sources, and syndicates seed-to-Series A equity investments into early-stage technology startups in the UK's Golden Triangle. The group facilitates investments between £100,000 and £2m in S/EIS eligible equity financing via monthly online pitching events, quarterly in-person events, and an exclusive online deal flow platform, targeting 5X+ returns over a 5-8 year horizon through AIM listings and trade sales.

Product overview

Cambridge Capital Group is a private business angel network, not a product company. It does not offer a unified product platform or software products. Instead, it provides investment services connecting angel investors with early-stage technology startups in the UK's Golden Triangle (Cambridge, London, Oxford). The organization facilitates deal flow screening, investment pitching events (monthly online and quarterly face-to-face), syndicated investments, and due diligence collaboration among its members. The investment vehicle itself is not a product offering in the traditional SaaS or technology product sense.

Differentiator

Problem solved

Functional benefit

Brands

  • CCG International: International network of private investors providing well-screened investment opportunities in hi-tech sectors including engineering, internet, software, artificial intelligence, medtech, biotech, electronics, fintech and wireless communications.
  • The CCG Trust

Products and services

  • Angel Investment Syndication Service

Quantifiable outcome

  • 22 successful exits via AIM listings and trade sales
  • +3 more outcomes

Companies that use Cambridge Capital Group

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Cambridge Capital Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Cambridge Capital Group partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Bailey FishercoreGTM or Marketing PartnerCorporate sponsor and dinner sponsor for CCG events. Provides investment expertise and networking for members.
  • Potter Clarkson LLPcoreImplementation/ SI/ Consulting PartnerCorporate sponsor providing IP legal advice and guidance to CCG portfolio companies.
  • RSMcoreImplementation/ SI/ Consulting PartnerCorporate sponsor providing financial advisory services to CCG and portfolio companies.
  • HCR HewitsonscoreImplementation/ SI/ Consulting PartnerCorporate sponsor providing legal services to CCG and portfolio companies.
  • Letts GroupminorGTM or Marketing PartnerCorporate sponsor providing incubator and advisory services. Dinner sponsor for CCG events.
  • CCG InternationalcoreStrategic or Co-development PartnerInternational network of private investors for growth stage investment in portfolio companies. Extends CCG's reach to family offices, private trusts, and international investors in hi-tech sectors.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Cambridge Capital Group competitors and assessment

Company assessment

Direct peers

  • Cambridge Angels: Cambridge-based business angel network investing in early-stage technology companies spun out of the University of Cambridge and the wider UK tech ecosystem. Directly comparable in geography, deal stage (seed to Series A), and member profile to Cambridge Capital Group.
  • London Business Angels: One of the UK's most established angel networks, operating in the London market and investing in seed to Series A technology startups. Directly comparable in deal stage, member composition, and structured event-based pitch process.
  • Oxford Investment Opportunity Network (OION): Oxford-based angel network focused on early-stage investment opportunities emerging from the Oxford innovation ecosystem. Directly comparable as a Golden Triangle angel network with similar member-driven, event-based deal-sourcing model.
  • Start Codon: Cambridge-based life science and healthcare seed fund that co-invests with CCG in life sciences opportunities. Comparable in early-stage focus and Cambridge cluster positioning, though specialized in the life sciences vertical.
  • Cambridge Enterprise Ventures: University of Cambridge's technology transfer and seed investment arm, leading funding rounds in Cambridge spinouts. Directly comparable as the most active co-investor in CCG's deal flow and the principal source of Cambridge spinout deal flow.
  • Parkwalk Advisors: UK-based investor in university spinouts from the Golden Triangle, frequently co-investing with CCG (e.g., Semarion). Comparable as an early-stage technology investor focused on Cambridge and Oxford spinouts with similar return profile.

Emerging players

  • QantX: Early-stage investor in healthtech and deeptech, based in the Cambridge/South West UK ecosystem and co-investing with CCG (e.g., iFAST Diagnostics). Comparable as a regional specialist investor in deep tech, with a more focused sector mandate.
  • SyndicateRoom: Online angel investment platform that uses a 'funding circle' model to allow members to co-invest in early-stage UK companies. Comparable in providing HNW investors with diversified early-stage deal flow, but with a digital-first delivery model.

Broad incumbents

  • British Business Bank: UK government-backed development bank that sponsors CCG events and supports SME investment through programmes such as the Angel CoFund. Comparable in supporting the UK angel ecosystem and providing catalytic capital to early-stage ventures.
  • Octopus Ventures: One of the UK's largest venture capital firms, actively investing across seed to growth stages in UK technology. Comparable as a co-investor in Cambridge ecosystem deals (e.g., SwiftKey) but at materially larger AUM and broader sector mandate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Cambridge Capital Group social profiles

Digital presence

Cambridge Capital Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cambridge Capital Group leadership team

Management profile

Number of profiles

Profiles2 records

Cambridge Capital Group subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Cambridge Capital Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cambridge Capital Group M&A and investment

M&A and investment

M&A

Investments45 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cambridge Capital Group

What does Cambridge Capital Group do?

Cambridge Capital Group is a business angel network of 80+ private investors, family offices, and venture funds that screens, sources, and syndicates seed-to-Series A equity investments into early-stage technology startups in the UK's Golden Triangle. The group facilitates investments between £100,000 and £2m in S/EIS eligible equity financing via monthly online pitching events, quarterly in-person events, and an exclusive online deal flow platform, targeting 5X+ returns over a 5-8 year horizon through AIM listings and trade sales.

Is Cambridge Capital Group a public or private company?

Cambridge Capital Group is a private company. It is classified as management employee owned and is currently operating.

When was Cambridge Capital Group founded?

Cambridge Capital Group was founded in 2000. It employs 11 to 50 people.

Where is Cambridge Capital Group based?

Cambridge Capital Group is headquartered in Cambridge, United Kingdom, in the Europe region.

How does Cambridge Capital Group make money?

One revenue line is on record: investment Returns.

Who are Cambridge Capital Group's main competitors?

Direct peers on record are Cambridge Angels, London Business Angels, Oxford Investment Opportunity Network (OION), Start Codon, Cambridge Enterprise Ventures and Parkwalk Advisors. Emerging players are QantX and SyndicateRoom. Broad incumbents are British Business Bank and Octopus Ventures.

Does Cambridge Capital Group have an API?

No public API is recorded for Cambridge Capital Group.

What industry is Cambridge Capital Group in?

Cambridge Capital Group's product category is Angel Investment / Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSAEAMAE, Private Capital Introducers (PE/VC/Private Credit). Its NAICS code is 52394 and its SIC code is 6799.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartupmagFuse Diagnostics raises £1m led by FSE Group with Cambridge Capital GroupFuse Diagnostics raised £1m in a pre-seed round led by FSE Group with Cambridge Capital Group to commercialise its Flip molecular diagnostics platform. The funding will accelerate assay development and validation across industrial and environmental markets, including food safety, water monitoring, and bioprocessing.Tech.euiFAST Diagnostics bags £5M to speed up infection testing and tackle antimicrobial resistanceiFAST Diagnostics closed a £5 million funding round led by Meridian Health Ventures, valuing the company at nearly five times its previous valuation. The rapid antimicrobial susceptibility testing platform delivers results in under three hours, and the funding will support UK rollout, EU approval, and US FDA clearance.News-MedicalSemarion secures $3.8 million to scale next-generation cell assay technology and accelerate pharma adoptionSemarion raised $3.8 million led by Parkwalk to scale its SemaCyte cell assay platform. The funding will expand manufacturing and field support, with adoption by top 10 pharma companies and collaborations with Revvity and SPT Labtech.FinSMEsOval Medical Receives Seed FundingOval Medical Technologies raised seed funding from Team Consulting, joining The Cambridge Angels and Cambridge Capital Group for nearly £0.5m in equity. The capital will advance its injection technology, including new drug containers and prototype devices for pharmaceutical validation. Team Consulting's CEO Jerry Turner will join the board.